Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours ; volume:13 ; number:1 ; day:13 ; month:3 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (13.3.2023), 1-10, 12.2023
- Urheber
-
O’Haire, Sophie
Franchini, Fanny
Kang, Yoon-Jung
Steinberg, Julia
Canfell, Karen
Desai, Jayesh
Fox, Stephen
IJzerman, Maarten
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-31055-3
- URN
-
urn:nbn:de:101:1-2408070920434.105627319676
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- O’Haire, Sophie
- Franchini, Fanny
- Kang, Yoon-Jung
- Steinberg, Julia
- Canfell, Karen
- Desai, Jayesh
- Fox, Stephen
- IJzerman, Maarten
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations